Navigation
banner

All posts by Satish Medicetty

Dr. Medicetty is GTCbio’s President and has a great vision to create impactful platforms that bring together right people to drive the future of science and medicine. He is a biotech entrepreneur and his background includes a unique blend of executive management, business development and scientific expertise. He received a degree (BVSc – equivalent to DVM) in Veterinary Medicine from A.N.G.R.A.University, India. He received a PhD from Kansas State University, Manhattan, KS. Later, he received his MBA from Weatherhead School of Management, CWRU, Cleveland, OH.

2017

Cogentis Therapeutics is the Winner of the New Company/Technology Pitch Competition at the CNS Diseases Summit

Satish Medicetty | September 21st, 2017

We were truly excited to conduct our inaugural new company/technology pitch competition at last week’s CNS diseases summit in Boston, MA. Four finalists, Orion Biosciences, Cogentis Therapeutics, Neurolucent and Acelot, participated in this fast-paced pitch session that included rating from judges as well as audience. The judges, Christine Brennan from MRL Ventures, Barbara Tate from…read more

Next Generation Sequencing

GTCbio | September 8th, 2017

Nucleotide sequencing is the method used for determining the precise order of nucleotides within a DNA/RNA molecule. The identification of complete gene and the complete genome of Bacteriophage MS2 in 1972 and 1976 respectively; and the invention of the first method for DNA sequencing involving a location-specific primer extension strategy in 1970 were the major…read more